Find the latest news about Inaphaea BioLabs here
We are delighted to welcome Dr Gareth Griffiths to Inaphaea BioLabs as Scientific Consultant in our Scientific Advisory Support team. Gareth holds a PhD in Immunology and Oncology from the University of…
Earlier this year, our parent company ValiRx announced the launch of Inaphaea BioLabs – a subsidiary company offering a wide range of pre-clinical and drug discovery testing services to academic, biotech, and…
This roundup covers our news, updates, and highlights from July. It has been a particularly busy time for Inaphaea, and we’re looking forward to the lab’s official launch event with BioNow on…
Inaphaea has signed a Master Services Agreement and Project Statement of Work with a UK based biotech company. The first invoice has been issued relating to the work, with subsequent invoices anticipated…
In our new monthly news roundups, we will be sharing our news, updates, and highlights from the past few weeks.
In the second instalment of our ‘meet the team’ series for Inaphaea BioLabs, we discover a little more about Melissa Barr.
Inaphaea BioLabs has entered into an agreement with virtual CRO services company, OncoBone Limited.
ValiRx PLC, parent company of Inaphaea BioLabs, has announced the acquisition of the scientific assets of Imagen Therapeutics Limited.
Inaphaea are experts in developing immunoassays based on hormones and cytokines at our labs in MediCity, Nottingham as we strive to find new therapies in women’s health. In addition to our pre-validated…
At our Inaphaea labs in MediCity, Nottingham we provide a comprehensive range of validated assays such as cell cancer assays or can provide assay development and validation for your bespoke assay as…